Shlomo Bulvik

2.0k total citations
32 papers, 1.3k citations indexed

About

Shlomo Bulvik is a scholar working on Genetics, Molecular Biology and Hematology. According to data from OpenAlex, Shlomo Bulvik has authored 32 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Genetics, 13 papers in Molecular Biology and 10 papers in Hematology. Recurrent topics in Shlomo Bulvik's work include Mesenchymal stem cell research (9 papers), Pluripotent Stem Cells Research (5 papers) and Neurogenesis and neuroplasticity mechanisms (5 papers). Shlomo Bulvik is often cited by papers focused on Mesenchymal stem cell research (9 papers), Pluripotent Stem Cells Research (5 papers) and Neurogenesis and neuroplasticity mechanisms (5 papers). Shlomo Bulvik collaborates with scholars based in Israel, United States and South Africa. Shlomo Bulvik's co-authors include Daniel Offen, Eldad Melamed, Ohad Karnieli, Shimon Efrat, Yael Barhum, Tali Ben‐Zur, Yossef S. Levy, Moshe Phillip, Liat de Vries and Ran Barzilay and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Shlomo Bulvik

31 papers receiving 1.3k citations

Peers

Countries citing papers authored by Shlomo Bulvik

Since Specialization

Citations

This map shows the geographic impact of Shlomo Bulvik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shlomo Bulvik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shlomo Bulvik more than expected).

Fields of papers citing papers by Shlomo Bulvik

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shlomo Bulvik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shlomo Bulvik. The network helps show where Shlomo Bulvik may publish in the future.

Co-authorship network of co-authors of Shlomo Bulvik

This figure shows the co-authorship network connecting the top 25 collaborators of Shlomo Bulvik. A scholar is included among the top collaborators of Shlomo Bulvik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shlomo Bulvik. Shlomo Bulvik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Primary plasma cell leukemia in the era of novel agents for myeloma – a multicenter retrospective analysis of outcome 2018 ·Leukemia Research ·Chezi Ganzel, Ory Rouvio, Irit Avivi, Hila Magen, (unknown), (unknown), Yossi Cohen, Tamar Tadmor, (unknown), Merav Leiba, Arnon Nagler, Yaël C. Cohen, Shlomo Bulvik, Aaron Polliack, Jacob M. Rowe, Moshe E. Gatt	10
2	Ruxolitinib treatment for myelofibrosis: Efficacy and tolerability in routine practice 2015 ·Leukemia Research ·Martin Ellis, Noa Lavi, Elena Mishchenko, Najib Dally, David Lavie, (unknown), Odit Gutwein, Shlomo Bulvik, Andrei Braester, Evgeni Chubar, Sigal Tavor, Adrian Duek, Ilya Kirgner, Maya Koren‐Michowitz	7
3	Characterization of human sporadic ALS biomarkers in the familial ALS transgenic mSOD1G93A mouse model 2013 ·Human Molecular Genetics ·(unknown), (unknown), Leonardo J. Solmesky, (unknown), Noga Gershoni‐Emek, Shlomo Bulvik, Ibrahim Kassis, Dimitrios Karussis, Eran Perlson, Miguel Weil	17
4	Two Potential Biomarkers Identified in Mesenchymal Stem Cells and Leukocytes of Patients with Sporadic Amyotrophic lateral Sclerosis 2012 ·Disease Markers ·(unknown), (unknown), (unknown), Shlomo Bulvik, Miguel Weil	13
5	The Clinical Response of West Nile Virus Neuroinvasive Disease to Intravenous Immunoglobulin Therapy 2012 ·SHILAP Revista de lepidopterología ·Zvi Shimoni, Hanna Bin, Shlomo Bulvik, Mark Niven, Rawi Hazzan, Ella Mendelson, Paul Froom	16
6	Bone Morphogenetic Protein Signaling Is Involved in Human Mesenchymal Stem Cell Survival in Serum-Free Medium 2009 ·Stem Cells and Development ·Leonardo J. Solmesky, (unknown), Shlomo Bulvik, Miguel Weil	16
7	Two cycles of escalated BEACOPP followed by four cycles of ABVD utilizing early-interim PET/CT scan is an effective regimen for advanced high-risk Hodgkin's lymphoma 2009 ·Annals of Oncology ·Abraham Avigdor, Shlomo Bulvik, (unknown), Eldad J. Dann, Noga Shem‐Tov, Galit Perez‐Avraham, Avichai Shimoni, Arnon Nagler, Isaac Ben‐Bassat, Aaron Polliack	71
8	Thymic involution, a co‐morbidity factor in amyotrophic lateral sclerosis 2009 ·Journal of Cellular and Molecular Medicine ·Akop Seksenyan, Noga Ron‐Harel, David Azoulay, Liora Cahalon, Michal Cardon, Patrícia Soares Rogeri, MinHee K. Ko, Miguel Weil, Shlomo Bulvik, Gideon Rechavi, Ninette Amariglio, Eli Konen, Maya Koronyo‐Hamaoui, Raz Somech, Michal Schwartz	32
9	Protective Effects of Neurotrophic Factor–Secreting Cells in a 6-OHDA Rat Model of Parkinson Disease 2009 ·Stem Cells and Development ·Ofer Sadan, (unknown), Yael Barhum, Yossef S. Levy, (unknown), (unknown), (unknown), Shlomo Bulvik, Noam Shemesh, Dana Krepel, Yoram Cohen, Eldad Melamed, Daniel Offen	127
10	Induction of Adult Human Bone Marrow Mesenchymal Stromal Cells into Functional Astrocyte-Like Cells: Potential for Restorative Treatment in Parkinson’s Disease 2009 ·Journal of Molecular Neuroscience ·(unknown), Yael Barhum, Yossef S. Levy, (unknown), Shlomo Bulvik, Eldad Melamed, Daniel Offen	71
11	Lentiviral Delivery of LMX1a Enhances Dopaminergic Phenotype in Differentiated Human Bone Marrow Mesenchymal Stem Cells 2008 ·Stem Cells and Development ·Ran Barzilay, Tali Ben‐Zur, Shlomo Bulvik, Eldad Melamed, Daniel Offen	46
12	Regenerative effect of neural-induced human mesenchymal stromal cells in rat models of Parkinson's disease 2008 ·Cytotherapy ·Yochai Levy, (unknown), Ran Barzilay, (unknown), Shlomo Bulvik, Yael Barhum, Hana Panet, E. Melamed, Daniel Offen	101
13	Induction of Human Mesenchymal Stem Cells into Dopamine-Producing Cells with Different Differentiation Protocols 2008 ·Stem Cells and Development ·Ran Barzilay, (unknown), Tali Ben‐Zur, Shlomo Bulvik, Eldad Melamed, Daniel Offen	72
14	Dopaminergic differentiation of human mesenchymal stem cells—Utilization of bioassay for tyrosine hydroxylase expression 2007 ·Neuroscience Letters ·(unknown), Tali Ben‐Zur, Yael Barhum, Yossef S. Levy, (unknown), (unknown), Shlomo Bulvik, Eldad Melamed, Daniel Offen	47
15	Combined escBEACOPP-ABVD Therapy for Advanced Hodgkin’s Lymphoma Patients with High IPS Score: An Effective Regimen and Low Positive Predictive Value of Early FDG-PET/CT Scan. 2007 ·Blood ·Abraham Avigdor, Shlomo Bulvik, Eldad J. Dann, Itai Levi, Galit Perez‐Avraham, Noga Shem‐Tov, Avichai Shimoni, Arnon Nagler, Isaac Ben‐Bassat, Aaron Polliack	6
16	Human Mesenchymal Stem Cells Express Neural Genes, Suggesting a Neural Predisposition 2006 ·Stem Cells and Development ·(unknown), Yossef S. Levy, Tali Ben‐Zur, (unknown), (unknown), (unknown), (unknown), (unknown), Yael Barhum, Shlomo Bulvik, Eldad Melamed, Daniel Offen	135
17	Severe factor XI deficiency caused by a Gly555 to Glu mutation (factor XI–Glu555): a cross‐reactive material positive variant defective in factor IX activation 2004 ·Journal of Thrombosis and Haemostasis ·Ariella Zivelin, Taketoshi Ogawa, Shlomo Bulvik, Meytal Landau, John R. Toomey, Jonathan D. Lane, Uri Seligsohn, David Gailani	20
18	Laparoscopic splenectomies for idiopathic thrombocytopenic purpura: Experience of sixty cases 2000 ·American Journal of Hematology ·Amir Szold, (unknown), Subhi Abu‐Abeid, Shlomo Bulvik, Amiram Eldor	29
19	High-Dose Dexamethasone for Splenectomy in Patients with Idiopathic Thrombocytopenic Purpura 1998 ·Pathophysiology of Haemostasis and Thrombosis ·Shlomo Bulvik, Asher Winder, Ofira Ben‐Tal, Amir Szold, Amiram Eldor	4
20	Extensive bone marrow necrosis associated with antiphospholipid antibodies 1995 ·The American Journal of Medicine ·Shlomo Bulvik, Ingrid Aronson, Stanley Ress, Peter Jacobs	30

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact